Tag: PEPITES study

Viaskin Peanut

DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy

"This submission represents a significant step forward for those families living with peanut allergy."
DBV Patch Closeup

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.
Viaskin Peanut

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...

The study received higher-than-expected patient demand.

Connect with Us

38,196FansLike
595FollowersFollow
2,663FollowersFollow
5,445FollowersFollow
38SubscribersSubscribe